200 related articles for article (PubMed ID: 9365244)
1. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.
Gao SJ; Boshoff C; Jayachandra S; Weiss RA; Chang Y; Moore PS
Oncogene; 1997 Oct; 15(16):1979-85. PubMed ID: 9365244
[TBL] [Abstract][Full Text] [Related]
2. Suppression of oncogenic viral interferon regulatory factor (vIRF) of Kaposi's sarcoma-associated herpesvirus by ribozyme-mediated cleavage.
Zhang YJ; Wang XP; Deng JH; Salinas RA; Oishi N; Gao SJ
Cancer Gene Ther; 2001 Apr; 8(4):285-93. PubMed ID: 11393281
[TBL] [Abstract][Full Text] [Related]
3. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators.
Lin R; Genin P; Mamane Y; Sgarbanti M; Battistini A; Harrington WJ; Barber GN; Hiscott J
Oncogene; 2001 Feb; 20(7):800-11. PubMed ID: 11314014
[TBL] [Abstract][Full Text] [Related]
4. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein.
Seo T; Lee D; Lee B; Chung JH; Choe J
Biochem Biophys Res Commun; 2000 Apr; 270(1):23-7. PubMed ID: 10733899
[TBL] [Abstract][Full Text] [Related]
5. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
6. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha.
Flowers CC; Flowers SP; Nabel GJ
Mol Med; 1998 Jun; 4(6):402-12. PubMed ID: 10780883
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.
Chen J; Ueda K; Sakakibara S; Okuno T; Yamanishi K
J Virol; 2000 Sep; 74(18):8623-34. PubMed ID: 10954564
[TBL] [Abstract][Full Text] [Related]
10. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus.
Wang XP; Zhang YJ; Deng JH; Pan HY; Zhou FC; Montalvo EA; Gao SJ
Oncogene; 2001 Jan; 20(4):523-30. PubMed ID: 11313983
[TBL] [Abstract][Full Text] [Related]
12. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
Chang H
J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
[TBL] [Abstract][Full Text] [Related]
13. Auto-activation of the transforming viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).
Wang XP; Gao SJ
J Gen Virol; 2003 Feb; 84(Pt 2):329-336. PubMed ID: 12560564
[TBL] [Abstract][Full Text] [Related]
14. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.
Burger M; Burger JA; Hoch RC; Oades Z; Takamori H; Schraufstatter IU
J Immunol; 1999 Aug; 163(4):2017-22. PubMed ID: 10438939
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein.
Fuld S; Cunningham C; Klucher K; Davison AJ; Blackbourn DJ
J Virol; 2006 Mar; 80(6):3092-7. PubMed ID: 16501120
[TBL] [Abstract][Full Text] [Related]
16. The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.
Wies E; Hahn AS; Schmidt K; Viebahn C; Rohland N; Lux A; Schellhorn T; Holzer A; Jung JU; Neipel F
J Biol Chem; 2009 Mar; 284(13):8525-38. PubMed ID: 19129183
[TBL] [Abstract][Full Text] [Related]
17. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
[TBL] [Abstract][Full Text] [Related]
18. An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression.
Rubinstein YR; Driggers PH; Ogryzko VV; Thornton AM; Ozato K; Pontzer CH
Oncogene; 2000 Mar; 19(11):1411-8. PubMed ID: 10723132
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.
Lubyova B; Kellum MJ; Frisancho AJ; Pitha PM
J Biol Chem; 2004 Feb; 279(9):7643-54. PubMed ID: 14668346
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p53 tumor suppressor by viral interferon regulatory factor.
Nakamura H; Li M; Zarycki J; Jung JU
J Virol; 2001 Aug; 75(16):7572-82. PubMed ID: 11462029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]